A Review on the Effect of COVID-19 in Pregnant Women
Pharmaceutical and Biomedical Research
; 6(SpecialIssue1):17-26, 2020.
Artigo
em Inglês
| EMBASE | ID: covidwho-20241664
ABSTRACT
Coronavirus Disease 2019 (COVID-19) is an emerging disease with a rapid increase in cases and deaths since its first discovery in December 2019, in Wuhan, China. Limited data are available on COVID-19 effects during pregnancy;however, information on diseases associated with other highly pathogenic coronaviruses (i.e. Severe Acute Respiratory Syndrome [SARS] and the Middle East respiratory syndrome [MERS]) may provide insight into the effects of COVID-19 during pregnancy. Coronaviruses cause illnesses ranging from the common cold to severe respiratory disease and death. The data indicate an average of 5 days incubation period (range 2-14 days). The average age range of the hospitalized patients was 49-56 years, and a third to half of them have an underlying illness. Children were rarely mentioned. Within hospitalized cases, men were more frequent (54%-73%). Fever, cough, myalgia, vomiting, and diarrhea are common symptoms. This review aims at giving an in-depth understanding of COVID-19 by comparing its effects with SARS and MERS to evaluate its severity in pregnant women1. The results of varied studies show that COVID-19 affects pregnant women seriously and there is an alarming need to look into this aspect to prevent its harmful effects on the fetus.Copyright © 2020
Coronavirus; covid-19; mers; Pregnancy; sars; antiretroviral therapy; article; artificial ventilation; computer assisted tomography; coronavirus disease 2019/dt [Drug Therapy]; coughing; diarrhea; dyspnea; epidemic; extracorporeal oxygenation; fatigue; fever; ground glass opacity; headache; health care personnel; hospitalization; human; influenza; leukocytosis; lymphocytopenia; malaise; Middle East respiratory syndrome; Middle East respiratory syndrome coronavirus; myalgia; nausea; neutrophilia; pleura effusion; pneumonia; pregnant woman; preterm rupture of membranes; quarantine; reverse transcription polymerase chain reaction; SARS coronavirus; severe acute respiratory syndrome; sore throat; stillbirth; thorax radiography; thrombocytopenia; virus transmission; vomiting; alanine aminotransferase/ec [Endogenous Compound]; aspartate aminotransferase/ec [Endogenous Compound]; ceftazidime/dt [Drug Therapy]; cephalosporin/dt [Drug Therapy]; D dimer/ec [Endogenous Compound]; lopinavir/dt [Drug Therapy]; macrolide/dt [Drug Therapy]; magnesium sulfate/dt [Drug Therapy]; moxifloxacin/dt [Drug Therapy]; oseltamivir/dt [Drug Therapy]; ritonavir/dt [Drug Therapy]
Texto completo:
Disponível
Coleções:
Bases de dados de organismos internacionais
Base de dados:
EMBASE
Tipo de estudo:
Estudo experimental
/
Estudo prognóstico
Idioma:
Inglês
Revista:
Pharmaceutical and Biomedical Research
Ano de publicação:
2020
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS